|
|||||
|
|
Dose considerations for anti‐cancer drugs in metastatic prostate cancer |
|
| Authors: | Megan Crumbaker Howard Gurney |
| Affiliation: | 1. Crown Princess Mary Cancer Care Centre, Westmead Hospital, New South Wales, Australia;2. Kinghorn Cancer Centre, Darlinghurst, New South Wales, Australia;3. Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia;4. Macquarie University, New South Wales, Australia |
| Abstract: | |
| Keywords: | dosing prostate cancer treatment |